Gene · 5500
Papers1,416
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,416
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches. | Chin Herb Med | 2023 | 37220535 | PubTator, text mining | PubMed |
| Editorial: Tumor microenvironment in bladder cancer. | Front Oncol | 2023 | 37207141 | PubTator, text mining | PubMed |
| HIV infection and cardiovascular disease have both shared and distinct monocyte gene expression features: Women's Interagency HIV study. | PLoS One | 2023 | 37205656 | PubTator, text mining | PubMed |
| Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics. | Bioimpacts | 2023 | 37193075 | PubTator, text mining | PubMed |
| Integrative Analysis of the Predictive Value of Perilipin Family on Clinical Significance, Prognosis and Immunotherapy of Glioma. | Biomedicines | 2023 | 37189627 | PubTator, text mining | PubMed |
| Comprehensive analysis of alternative polyadenylation regulators of CTLA4 and immune infiltration in clear cell renal cell carcinoma. | Transl Androl Urol | 2023 | 37181233 | PubTator, text mining | PubMed |
| Prenatal Diagnosis of Euploid Increased Nuchal Translucency on Fetal Ultrasound (II): RASopathy Disorders - Prenatal Ultrasound Findings and Genotype-phenotype Correlations. | J Med Ultrasound | 2023 | 37180632 | PubTator, text mining | PubMed |
| NF2 alteration in mesothelioma. | Front Toxicol | 2023 | 37180489 | PubTator, text mining | PubMed |
| Genetic comparison of transmissible gastroenteritis coronaviruses. | Front Vet Sci | 2023 | 37138909 | PubTator, text mining | PubMed |
| Cofilin activation in pancreatic acinar cells plays a pivotal convergent role for mediating CCK-stimulated enzyme secretion and growth. | Front Physiol | 2023 | 37138671 | PubTator, text mining | PubMed |
| Structural analysis of the coronavirus main protease for the design of pan-variant inhibitors. | Sci Rep | 2023 | 37120654 | PubTator, text mining | PubMed |
| Hub genes and pathways in gastric cancer: A comparison between studies that used normal tissues adjacent to the tumour and studies that used healthy tissues as calibrator. | IET Syst Biol | 2023 | 37118990 | PubTator, text mining | PubMed |
| Severe COVID-19: Drugs and Clinical Trials. | J Clin Med | 2023 | 37109231 | PubTator, text mining | PubMed |
| Comparative analysis of newly identified rodent arteriviruses and porcine reproductive and respiratory syndrome virus to characterize their evolutionary relationships. | Front Vet Sci | 2023 | 37077949 | PubTator, text mining | PubMed |
| FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms. | Biomed Pharmacother | 2023 | 37068330 | PubTator, text mining | PubMed |
| Effect of coronaviruses on blood vessel permeability: potential therapeutic targets. | Ther Adv Respir Dis | 2023 | 37067023 | PubTator, text mining | PubMed |
| A retrospective analysis of phosphatase catalytic subunit gene variants in patients with rare disorders identifies novel candidate neurodevelopmental disease genes. | Front Cell Dev Biol | 2023 | 37056996 | PubTator, text mining | PubMed |
| SARS-CoV-2 polyprotein substrate regulates the stepwise Mpro cleavage reaction. | J Biol Chem | 2023 | 37044215 | PubTator, text mining | PubMed |
| COVID-19 in early 2023: Structure, replication mechanism, variants of SARS-CoV-2, diagnostic tests, and vaccine & drug development studies. | MedComm (2020) | 2023 | 37041762 | PubTator, text mining | PubMed |
| Editorial: Using novel technologies and models to identify biomarkers and explore therapeutic strategies for neurological disorders. | Front Behav Neurosci | 2023 | 37035626 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5500/papers?page=7